Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis

Gottenberg, J E; Courvoisier, D S; Hernandez, M V; Iannone, F; Lie, E; Canhão, H; Pavelka, K; Hetland, M L; Turesson, C; Mariette, X; Finckh, Axel

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
Authors		Gottenberg, J E Courvoisier, D S Hernandez, M V Iannone, F Lie, E Canhão, H Pavelka, K Hetland, M L Turesson, C Mariette, X Finckh, Axel show all authors [1 - 11]
Published in		Arthritis and Rheumatology. 2016, vol. 68, no. 6, p. 1346-52
Abstract		To investigate the role of rheumatoid factor (RF) status and anti-citrullinated peptide antibody (ACPA) status as predictors of abatacept (ABA) effectiveness in patients with rheumatoid arthritis (RA).
Keywords		Abatacept/therapeutic use — Antirheumatic Agents/therapeutic use — Arthritis — Rheumatoid/blood/drug therapy — Autoantibodies/blood — Europe — Female — Humans — Male — Middle Aged — Peptides — Cyclic/immunology — Predictive Value of Tests — Registries — Rheumatoid Factor/blood — Treatment Outcome
Identifiers		DOI: 10.1002/art.39595 PMID: 26815727
Full text		Article (Published version) (142 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine interne
Research group		Mécanisme de l'inflammation articulaire (44)
Citation (ISO format)		GOTTENBERG, J E et al. Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis. In: Arthritis and Rheumatology, 2016, vol. 68, n° 6, p. 1346-52. https://archive-ouverte.unige.ch/unige:99160